• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Aromatic monoterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Monoterpenoids Aromatic monoterpenoids

Introduction to Cyclohexanol,5-methyl-2-(1-methyl-1-phenylethyl)-, (1S,2R,5S)- (CAS No. 57707-91-2)

The compound Cyclohexanol,5-methyl-2-(1-methyl-1-phenylethyl)-, (1S,2R,5S)-, identified by its CAS number 57707-91-2, is a complex organic molecule with a unique stereochemical configuration. This chiral alcohol belongs to the class of substituted cyclohexanols and has garnered significant attention in the field of pharmaceutical chemistry due to its structural complexity and potential biological activities. The presence of multiple stereocenters, specifically the (1S,2R,5S) configuration, makes this compound a subject of interest for synthetic chemists and pharmacologists exploring novel molecular architectures.

Structurally, Cyclohexanol,5-methyl-2-(1-methyl-1-phenylethyl)-, (1S,2R,5S)- features a cyclohexane ring substituted with a 5-methyl group and a 2-(1-methyl-1-phenylethyl) side chain. The stereochemistry at the 1st, 2nd, and 5th positions of the cyclohexane ring is crucial in determining its interactions with biological targets. The specific (1S,2R,5S) configuration suggests that this compound may exhibit distinct pharmacological properties compared to its stereoisomers. This stereochemical diversity is a key factor in drug design, as it can significantly influence binding affinity, metabolic stability, and overall efficacy.

In recent years, the study of chiral alcohols has seen considerable advancements due to their role as key intermediates in the synthesis of biologically active molecules. The compound Cyclohexanol,5-methyl-2-(1-methyl-1-phenylethyl)-, (1S,2R,5S)- is no exception. Researchers have been exploring its potential applications in the development of novel therapeutic agents. For instance, studies have indicated that substituted cyclohexanols can serve as scaffolds for designing molecules with anti-inflammatory and analgesic properties. The unique stereochemistry of this compound may contribute to its ability to modulate biological pathways effectively.

The synthesis of Cyclohexanol,5-methyl-2-(1-methyl-1-phenylethyl)-, (1S,2R,5S)- presents a significant challenge due to the need for precise stereocontrol. Advanced synthetic methodologies such as asymmetric hydrogenation and enzymatic resolution have been employed to achieve the desired configuration. These techniques not only highlight the progress in synthetic chemistry but also underscore the importance of stereochemistry in drug development. The successful synthesis of this compound demonstrates the growing capability of chemists to manipulate complex molecular structures with high precision.

From a biological perspective, the potential applications of Cyclohexanol,5-methyl-2-(1-methyl-1-phenylethyl)-, (1S,2R,5S)- are vast. Preliminary studies have suggested that it may interact with various enzymes and receptors involved in inflammatory responses. The presence of both hydroxyl and aromatic moieties in its structure could allow it to engage multiple binding sites simultaneously. This multitarget interaction is often desirable in drug design as it can lead to enhanced therapeutic effects and reduced side effects.

Furthermore, the compound's structural features make it an attractive candidate for further derivatization. By modifying specific functional groups or introducing additional substituents, researchers can explore new analogs with improved pharmacological profiles. This flexibility in structural design is a testament to the versatility of cyclohexanol derivatives as pharmacophores. The ongoing research into Cyclohexanol, (CAS No. 57707-91-2) and its derivatives continues to expand our understanding of their potential in medicinal chemistry.

The industrial significance of Cyclohexanol, (CAS No. 57707-91-2) cannot be overstated. As more research emerges on its applications in drug development and material science，its demand is likely to grow. Companies specializing in fine chemicals and pharmaceutical intermediates are increasingly investing in technologies that enable the efficient production of such complex molecules. This trend reflects the broader shift towards more sophisticated chemical synthesis methods that can meet the demands of modern drug discovery.

In conclusion,Cyclohexanol, (CAS No. 57707-91-2) stands as a remarkable example of how structural complexity can be leveraged to develop novel therapeutic agents。 Its unique stereochemistry， coupled with its versatile functional groups， makes it a valuable building block for future drug candidates。 As research progresses， we can expect even more innovative applications for this compound， further solidifying its role in pharmaceutical chemistry。

• 49673-74-7(Cyclohexanol, 3-phenyl-)
• 1444-64-0(2-Phenylcyclohexanol)
• 109527-45-9(Cyclohexanol,2-(1-methyl-1-phenylethyl)-, (1S,2R)-)
• 5437-46-7(4-Phenylcyclohexanol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)